Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor class drugs

5 results
Slate Run Pharmaceuticals, LLC
Usage: Ganciclovir for Injection is indicated for treating cytomegalovirus (CMV) retinitis in immunocompromised adults, including those with AIDS, and for preventing CMV disease in at-risk adult transplant recipients.

Valcyte (valganciclovir)

(valganciclovir)
Genentech, Inc.
Usage: VALCYTE is indicated for the treatment of cytomegalovirus (CMV) retinitis in adults with AIDS. It also prevents CMV disease in high-risk transplant patients: kidney, heart, and kidney-pancreas recipients, as well as pediatric kidney and heart transplant patients aged 1 month to 16 years.
Ajanta Pharma USA Inc.
Usage: Valganciclovir tablets are indicated for treating Cytomegalovirus (CMV) retinitis in AIDS patients and for preventing CMV disease in high-risk kidney, heart, and kidney-pancreas transplant recipients. It is also used in pediatric patients aged 1 month to 16 years for preventing CMV disease post-transplant.
Golden State Medical Supply, Inc.
Usage: Valganciclovir tablets are indicated for treating cytomegalovirus (CMV) retinitis in HIV/AIDS patients and for preventing CMV disease in high-risk kidney, heart, and kidney-pancreas transplant patients (adults) as well as in high-risk kidney and heart transplant pediatric patients aged 1 month to 16 years.
Ajanta Pharma USA Inc.
Usage: Valganciclovir is indicated for treating cytomegalovirus (CMV) retinitis in AIDS patients and for preventing CMV disease in high-risk transplant recipients (adults and pediatric patients) including kidney and heart transplants.